Anupam Rasayan Becomes First Global Company to Commercialize ETFA Using Flow Chemistry

Anupam Rasayan Becomes First Global Company to Commercialize ETFA Using Flow Chemistry​

Surat, June 11, 2026: Anupam Rasayan India Ltd., a leading specialty chemicals and custom synthesis company, has announced the commercialization of Ethyl trifluoroacetate (ETFA) through its proprietary process-by-design continuous flow chemistry platform. This achievement positions the Indian firm as the first globally to manufacture ETFA at a commercial scale utilizing advanced flow technology.

ETFA is described as a critical fluorinated building block and reagent used extensively in the synthesis of various organic fluorine compounds. These compounds are vital across the life sciences, pharmaceutical, and performance materials sectors, where they help enhance product efficacy and stability. The global addressable market for ETFA is estimated to be between USD 500 million and 600 million, highlighting its strategic importance within the specialty chemicals value chain.

The utilization of continuous flow chemistry offers significant advantages compared to conventional batch processes. These benefits include improved scalability, enhanced process safety, superior reproducibility, higher operational efficiency, and a lower environmental footprint. Through this innovation, Anupam Rasayan India Limited has secured a pioneering position in the industrial production of ETFA.

Key details regarding the product launch are summarized below:


Anand Desai, Managing Director of Anupam Rasayan, commented on the milestone. He stated that the commercialization of ETFA through their continuous flow chemistry platform represents a significant step in the company's innovation journey. This achievement validates their technological capabilities in complex fluorination chemistry and demonstrates their ability to develop scaled manufacturing solutions for evolving customer needs.

Anupam Rasayan India Ltd., incorporated in 1984, is a major player in specialty chemicals with two primary verticals: Life Science-related Specialty Chemicals (covering Agrochemicals, Personal Care, and Pharmaceuticals) and Performance Materials (focused on Electronics & EV Chemicals and Polymers). The company services a diverse base of over 75 domestic and international clients, including 31 multinational corporations.

As of March 31, 2026, Anupam operates through eight manufacturing facilities. Four facilities are located in Surat, and two are in Jhagadia, Bharuch. Two additional manufacturing facilities are managed via Jayhawk Fine Chemicals in the USA. The company's total installed capacity stands at approximately 30,000 MT in India and about 36,000 MT through its US operations. Anupam Rasayan provides multistep synthesis services, capturing a large portion of the value chain for its clientele.

ANURAS Stock Price Movement​

Anupam Rasayan India Limited finished the trading session lower today, shedding 1.44% to settle at ₹1258. The equity traded amidst an intraday range, with the stock logging a volume of 163,342 shares.